Frontlight ResearchEarly access
Colorectal cancer trials in China
616 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEffect of Surgical Margin Width on Recurrence and Survival in Patients With Hepatic Oligometastasis of Colorectal Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 140
- Run by
- Fudan University
See details and how to joinNCT06934018 - Phase 2/3Not yet taking people in ChinaA Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 590
- Run by
- Sun Yat-sen University
See details and how to joinNCT06959693 - No phaseNot yet taking people in ChinaPreservation Vs. Dissection of No. 253 Lymph Nodes of Robotic Resection for Mid/Low Rectal Cancer
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 1,596
- Run by
- Fudan University
See details and how to joinNCT06956976 - No phaseTaking peoplePrognostic Value of Neurometabolic Networks in CRC (PVNM-CRC)
- Where
- Henan
- Age
- 18 years and over
- People
- 213
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT06930586 - Phase 2Taking peopleTreating Locally Advanced Rectal Cancer With TAS-102 Chemotherapy Plus Neoadjuvant Radiotherapy
- Where
- Guangzhou
- Age
- 18 years to 70 years
- People
- 65
- Run by
- Sun Yat-sen University
See details and how to joinNCT05965531 - Phase 1Not yet taking people in ChinaTo Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors
- Where
- Guanzhou
- Age
- 18 years and over
- People
- 66
- Run by
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT06948539 - Phase 1Taking peopleExploratory Clinical Study of Claudin18.2-Targeted CAR-DC and CAR-T Therapy in Advanced Colorectal Cancer
- Where
- Hangzhou
- Age
- 18 years to 70 years
- People
- 18
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06946615 - No phaseTaking peopleExploration of the Dynamic Changes and Mechanisms of the Immune Microenvironment in Advanced Colorectal Cancer Treated With IBI363 Combination Therapy
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 50
- Run by
- jianming xu
See details and how to joinNCT06946745 - Early phase 1Taking peopleA Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Patients
- Where
- Shanghai
- Age
- 18 years and over
- People
- 9
- Run by
- Shanghai Changzheng Hospital
See details and how to joinNCT06621173 - No phaseTaking peopleRaman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
- Where
- Hangzhou, Nanchang, Shanghai
- People
- 600
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06822413 - No phaseNot yet taking people in ChinaSafety and Efficacy Study of Single-port Robotic Versus Multi-port Robotic Radical Rectal Cancer Surgery
- Where
- Jinan, Luoyang, Shanghai, Wenzhou
- Age
- 18 years to 80 years
- People
- 212
- Run by
- Ruijin Hospital
See details and how to joinNCT06943690 - No phaseTaking peopleReal-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors
- Where
- Shenyang
- Age
- 18 years and over
- People
- 120
- Run by
- Changchun GeneScience Pharmaceutical Co., Ltd.
See details and how to joinNCT06940102 - No phaseEnrolling by invitationA Prospective, Single Arm, Open Label, Phase II Clinical Study on the Efficacy and Safety of Ivonescimab (AK112) Combined With TAS-102 in the Treatment of Refractory MSS/pMMR Advanced Colorectal Cancer
- Where
- Huai'an
- Age
- 18 years to 75 years
- People
- 35
- Run by
- Huai'an First People's Hospital
See details and how to joinNCT06936488 - Phase 2Taking peopleModified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low LARC (MODIFI-RC-I)
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 80
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06923345 - No phaseTaking peopleProspective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
- Where
- Hong Kong
- Age
- 18 years to 80 years
- People
- 90
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT06926374 - Phase 2Taking peopleThe Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Therapy and Subsequent Lines.
- Where
- Shanghai
- Age
- 18 years and over
- People
- 60
- Run by
- Shanghai Changzheng Hospital
See details and how to joinNCT06930118 - Phase 2Taking peopleNeoadjuvant Short-Course Radiotherapy With or Without Chemotherapy and AK112 in Locally Advanced Rectal Cancer
- Where
- Chongqing
- Age
- 18 years to 80 years
- People
- 100
- Run by
- fan li
See details and how to joinNCT06718543 - Phase 1Taking peoplePhase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors
- Where
- Tianjin
- Age
- 18 years to 75 years
- People
- 780
- Run by
- Hansoh BioMedical R&D Company
See details and how to joinNCT06621563 - No phaseTaking peoplePreoperative Oral Midazolam to Postoperative Pain Relief in Sleep Disturbance or Anxiety Patients With Colorectal Cancer
- Where
- Guangzhou
- Age
- 18 years to 60 years
- People
- 280
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06407518 - No phaseTaking peopleA Prospective Multicentre Clinical Study of Dynamic Monitoring of Plasma ctDNA Methylation Markers to Predict Recurrence of Colorectal Cancer After Complete Resection of Peritoneal Metastases
- Where
- Shanghai
- Age
- 18 years and over
- People
- 50
- Run by
- Fudan University
See details and how to joinNCT06903325 - Phase 2Taking peopleCapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Locally Recurrent Colorectal Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 15
- Run by
- Shanghai Changzheng Hospital
See details and how to joinNCT06881537 - Phase 2Taking peoplePhase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer
- Where
- Anyang, Fuzhou, Huaian, Jinan, Kunming, Lanzhou, Shanghai, Taian, Xiamen, Zhengzhou
- Age
- 18 years and over
- People
- 208
- Run by
- Fudan University
See details and how to joinNCT06521866 - Phase 2Taking peopleDifferent Cycles of Preoperative Neoadjuvant Sintilimab in Mismatch-repair Deficient/microsatellite Instability-high, Locally Advanced Colorectal Cancer
- Where
- Zheng'zhou
- Age
- 18 years to 75 years
- People
- 96
- Run by
- Yugui Lian
See details and how to joinNCT06698757 - Phase 2Not yet taking people in ChinaShort-Course Radiotherapy Combined with Intracavitary Brachytherapy Followed by Pucotenlimab, Bevacizumab, Oxaliplatin, and Trifluridine/Tipiracil (TAS-102) for Total Neoadjuvant Therapy of Microsatellite Stable (MSS) Locally Advanced Low Rectal Cancer
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 33
- Run by
- Sir Run Run Shaw Hospital
See details and how to joinNCT06872606 - Phase 1/2Not yet taking people in ChinaTrial of Gum Chewing to Enhance the Restoration of Intestinal Motility in Colorectal Cancer Surgery
- Where
- Chengdu
- Age
- 18 years to 90 years
- People
- 292
- Run by
- Sichuan Cancer Hospital and Research Institute
See details and how to joinNCT06860685